UGT1A1 and Hyperbilirubinemia: In CNS2, also known as Arias’ disease [14], UGT1A1 activity is reduced but not completely absent, leading to less severe hyperbilirubinemia, with levels below 20 mg/dL, though they can rise to 40 mg/dL during acute exacerbations [15].